The Technical Analyst
PPD Inc [PPD]
Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
PPD Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $47.28
America/New_York / 31 des 1970 @ 19:00
| RATING 2022-02-09 |
|---|
| B- |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Neutral | |
| DE: | Strong Sell | |
| P/E: | Strong Buy | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/20 | 3/20 | 4/20 | 1/21 | 2/21 | 3/21 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE 47.78 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 47.13 - 47.43 ( +/- 0.32%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2021-12-08 | Carlyle Group Inc. | Sell | 55 722 733 | Common Stock |
| 2021-12-08 | H&f Corporate Investors Vii, Ltd. | Sell | 157 138 | Common Stock |
| 2021-12-08 | Johnston David Michael | Buy | 33 228 | Stock Options (Right to Buy) |
| 2021-12-08 | Johnston David Michael | Buy | 25 522 | Common Stock |
| 2021-12-08 | Johnston David Michael | Sell | 151 747 | Stock Options (Right to Buy) |
| INSIDER POWER |
|---|
| 0.00 |
| Last 98 transactions |
| Buy: 2 703 151 | Sell: 89 993 839 |
Forecast:
01:40 - $47.48
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $47.28 (0.00% ) |
| Volume | 1.868 mill |
| Avg. Vol. | 1.439 mill |
| % of Avg. Vol | 129.85 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For PPD
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
PPD
PPD, Inc. provides drug development services to the biopharmaceutical industry worldwide. The company operates through Clinical Development Services and Laboratory Services segments. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri- and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company was founded in 1985 and is headquartered in Wilmington, North Carolina.
Latest Press Releases
2022-02-02 08:00:00 - Press Release
Saama Appoints Scott Rogers As Company's Chief Financial Officer
Campbell, calif.--(business wire)-- #ai--veteran finance executive scott rogers appointed saama cfo following recent $430 million dollar growth investment announcement
2021-12-08 08:45:00 - Press Release
Thermo Fisher Scientific Completes Acquisition Of Ppd, Inc.
Waltham, mass., dec. 8, 2021 /prnewswire/ -- thermo fisher scientific inc. (nyse: tmo), the world leader in serving science, today announced that it has completed its acquisition of ppd, inc. (nasdaq: ppd), a leading global provider of clinical research services to the biopharma and biotech industry, for $17.4 billion.
2021-12-07 09:00:00 - Press Release
Ppd Named To ‘best Workplaces In Greater China' For Second Consecutive Year
Wilmington, n.c.--(business wire)--ppd was named one of the “best workplaces in greater china™ 2021” by great place to work® for successfully creating an inclusive workplace experience.
2021-12-07 09:00:00 - Press Release
Ppd Named To ‘best Workplaces In Greater China’ For Second Consecutive Year
Wilmington, n.c.--(business wire)--ppd, inc. (nasdaq: ppd) was named one of the “best workplaces in greater china™ 2021” by great place to work® for successfully creating an inclusive workplace experience for employees. ppd has more than 20 years of experience in the asia-pacific region, including providing a broad range of clinical development and laboratory services in greater china. this is the second year ppd has received this recognition from great place to work®, a global authority on high-trust, high-performance workplace cultures. “we remain committed to providing a healthy and open work environment for our employees, and this award shows that we continue to be successful in our efforts for yet another year,” said ding ming, ph...
2021-12-06 20:00:00 - Press Release
Ppd 連續第二年榮膺2021年度「大中華區最佳職場tm」稱號
北卡羅來納州威明頓--(business wire)--ppd, inc.（納斯達克代碼：ppd）被卓越職場（®great place to work®）評為「 2021年度大中華區最佳職場™ 」（best workplaces in greater china™），這都歸功於ppd為員工創造了包容性的職場體驗。 ppd在亞太地區擁有超過20年的經驗，包括在大中華區提供廣泛的臨床開發和實驗室服務。這是ppd第二年獲得卓越職場®這一機構的認可，該機構是一家關註高信任、高績效職場文化的全球權威機構。 ppd副總裁兼中國區總經理丁鳴博士表示： 「我們一直致力於為員工提供一個健康開放的工作環境，這個獎項表明我們的努力在新的一年裏繼續取得了成功。我們包容的文化、良好的員工關系和具有吸引力的福利，使得ppd在大中華區擁有良好的聲譽。在這個競爭激烈的市場中，我們將不斷提升作為首選雇主的標準，繼續致力於培養多元化的工作氛圍，吸引和招聘高素質的候選人，為我們的客戶提供高質量的服務。」 卓越職場®調查了中國大陸、香港和臺灣的150多家公司，以評估員工對所在公司領導團隊、組織文化的看法以及對組織的信任。ppd是61家榜上有名的公司之一。 ppd持續在亞太區擴展業務，為本地及全球客戶提供服務，提供跨區域的臨床運營服務。ppd在亞太區提供從i期到iv期的全程臨床試驗服務，包括臨床監查，項目管理，註冊事務，藥物警戒安全，臨床數據管理和病人招募。今年年初，ppd在蘇州開設一個全新的多功能臨床研究實驗室，為國外及中國本土的醫藥公司及生物科技公司提供生物分析、生物標誌物和疫苗研究服務，以支持他們在中國的研發。 關於ppd ppd是一家全球領先的醫藥研發外包服務公司（cro），提供全面的綜合藥物研發，實驗室與生命周期管理服務。我們的客戶及合作夥伴包括製藥，生物技術，醫療器械，學術機構以及政府組織等。ppd在全球46個國家設有辦事處，擁有超過25,000名專業員工。ppd借助創新的前沿技術，專業的治療知識以及堅定的質量承諾，幫助客戶及合作夥伴降低藥物開發的成本和時間，並優化價值，研製創新、有效和安全的醫療產品，為改善人類健康作出更大的貢獻。更多信息，請訪問公司官網：www...
Latest News
2021-10-28 11:49:06 - Seeking Alpha
PPD, Inc. (PPD) CEO David Simmons on Q3 2021 Results - Earnings Call Transcript
2021-10-27 20:14:22 - Zacks Investment Research
PPD, Inc. (PPD) Tops Q3 Earnings and Revenue Estimates
PPD, Inc. (PPD) delivered earnings and revenue surprises of 16.22% and 7.22%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
2021-10-18 16:05:00 - Business Wire
PPD Announces Third Quarter 2021 Earnings Conference Call
WILMINGTON, N.C.--(BUSINESS WIRE)--PPD Announces Third Quarter 2021 Earnings Conference Call
2021-07-31 14:54:04 - Seeking Alpha
PPD, Inc. (PPD) CEO David Simmons on Q2 2021 Results - Earnings Call Transcript
2021-07-28 20:29:19 - Zacks Investment Research
PPD, Inc. (PPD) Surpasses Q2 Earnings and Revenue Estimates
PPD, Inc. (PPD) delivered earnings and revenue surprises of 14.71% and 17.15%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
2021-04-16 11:24:00 - Business Wire
PPD Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of PPD, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – PPD
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of PPD, Inc. (NASDAQ: PPD) to Thermo Fisher Scientific Inc. for $47.50 per share is fair to PPD shareholders. Halper Sadeh encourages PPD shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether PPD and its board of
2021-04-16 09:04:11 - Zacks Investment Research
PPD, Inc. (PPD) Soars 6.5%: Is Further Upside Left in the Stock?
PPD, Inc. (PPD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
2021-04-15 12:29:45 - InvestorPlace
Midday Market Update: The 10 Most Active Stocks Today
It's time for the midday market update for Thursday as several companies are on the move with various increases and decreases. The post Midday Market Update: The 10 Most Active Stocks Today appeared first on InvestorPlace.
2021-04-15 07:37:00 - Business Wire
Medable Secures Another $78 Million Funding to Fuel Digital Innovation for Patient-Centered Drug Development
PALO ALTO, Calif.--(BUSINESS WIRE)-- #biotech--Medable announced $78 million in new funding to fuel advances in the delivery of decentralized clinical trials and patient-centered research.
2021-04-15 07:17:02 - Market Watch
Thermo Fisher to buy PPD, in a cash deal valued at $17.4 billion including debt
Shares of PPD Inc. rallied 7.3% in premarket trading Thursday, after Thermo Fisher Scientific Inc. confirmed an agreement to buy the pharmaceutical-testing company in a cash deal valued at $17.4 billion, including $3.5 billion in debt. Thermo Fisher shares gained 3.1% ahead of the open.